What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Per Ljungman focuses on Internal medicine, Transplantation, Immunology, Surgery and Hematopoietic stem cell transplantation.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Oncology.
His Transplantation research incorporates themes from Viral disease, Transplantation Conditioning, Aspergillosis and Letermovir.
His Immunology research includes elements of Disease and Intensive care medicine.
His study in Surgery is interdisciplinary in nature, drawing from both Incidence, Cumulative incidence and Bone marrow.
The various areas that Per Ljungman examines in his Hematopoietic stem cell transplantation study include Cord blood, Epstein–Barr virus infection, Hazard ratio, Cytotoxic T cell and Cidofovir.
His most cited work include:
- Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients (1034 citations)
- 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (861 citations)
- Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (413 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Transplantation, Immunology, Hematopoietic stem cell transplantation and Surgery.
His Internal medicine research includes themes of Gastroenterology and Oncology.
As a member of one scientific family, Per Ljungman mostly works in the field of Transplantation, focusing on Betaherpesvirinae and, on occasion, Congenital cytomegalovirus infection and Human cytomegalovirus.
The Immunology study combines topics in areas such as Disease and Virology.
His research integrates issues of Human leukocyte antigen, Myeloid leukemia, Hazard ratio, Transplantation Conditioning and Acute leukemia in his study of Hematopoietic stem cell transplantation.
In his study, Complication is inextricably linked to Bone marrow, which falls within the broad field of Surgery.
He most often published in these fields:
- Internal medicine (60.75%)
- Transplantation (58.26%)
- Immunology (52.75%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (60.75%)
- Transplantation (58.26%)
- Hematopoietic stem cell transplantation (38.54%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Hematology and Gastroenterology.
His study connects Oncology and Internal medicine.
His work carried out in the field of Transplantation brings together such families of science as Hematopoietic cell, Young adult, Placebo, Lymphoma and Sick leave.
His studies deal with areas such as Leukemia, Immunology, Vaccination, Cell therapy and Graft-versus-host disease as well as Hematopoietic stem cell transplantation.
His Immunology study frequently involves adjacent topics like Calcineurin.
His Gastroenterology research integrates issues from Viremia, Serostatus, Viral load, Hazard ratio and Acute leukemia.
Between 2017 and 2021, his most popular works were:
- European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia (98 citations)
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) (80 citations)
- Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Disease and Hematology are his primary areas of study.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His Transplantation research is multidisciplinary, incorporating perspectives in Letermovir, Young adult, Placebo, Leukemia and Risk factor.
His Hematopoietic stem cell transplantation study integrates concerns from other disciplines, such as Myelofibrosis, Itraconazole and Fluconazole.
His Disease study incorporates themes from Voriconazole, Posaconazole, Aspergillosis and Vaccination.
His Hematology research focuses on Intensive care medicine and how it relates to Pandemic, Developing country, Coronavirus disease 2019 and Medical tourism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
